Healthcare · Hepatitis B prevalence
Hepatitis B prevalence in the United States is just 0.1 %—one of the lowest rates globally, corresponding to 1-th place out of 197. This success is driven by universal newborn vaccination, introduced in 1991, and screening programs for pregnant women. Chronic carriers are mostly immigrants from Asia and Africa, where the virus is endemic. The native-born population, thanks to immunization, rarely encounters this infection.
Data for 2026 · unit: %
Position
#1 / 197
USA world ranking
Country position on the scale from last to first place for this indicator.
US
#1
#197#1
Trend
Change over time
Change in indicator over the available period.
0.3
1990
0.2
2000
0.1
2010
0.1
2020
0.1
2026
Values — %
Comparison
Top countries by Hepatitis B prevalence
Where USA stands in the world ranking.
1
GBUnited Kingdom
0.1
1
USUSA
0.1
1
NONorway
0.1
1
SESweden
0.1
1
ISIceland
0.1
1
VAVatican City
0.1
7
NLNetherlands
0.2
7
BEBelgium
0.2
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Hepatitis B prevalence in USA — how much?
Based on 2026 data — 0.1 %. This is rank #1 out of 197 countries.
What is USA's rank by Hepatitis B prevalence?
USA ranks #1 out of 197 countries in the world ranking by «Hepatitis B prevalence».
How has Hepatitis B prevalence changed in USA?
Over the available period the indicator changed from 0.3 to 0.1 %.